Does intramedullary plugging reduce blood transfusion requirements in total knee replacement?
ISRCTN | ISRCTN94713892 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN94713892 |
Secondary identifying numbers | Version 1, dated 24.08.09 |
- Submission date
- 18/12/2009
- Registration date
- 09/02/2010
- Last edited
- 31/05/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Shawn Tavares
Scientific
Scientific
Consultant Orthopaedic Surgeon
Trauma and Orthopaedic Department
Royal Berkshire NHS Foundation Trust
London Road
Reading
RG1 5AN
United Kingdom
Study information
Study design | Randomised controlled parallel-group trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised parallel trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
Scientific title | Does intramedullary plugging reduce blood transfusion requirements in total knee replacement? A randomised controlled clinical trial |
Study objectives | To assess if intramedullary plugging, when used together with an autologous retransfusion drain, reduces blood loss to make significant differences in allogenic blood requirements in patients undergoing total knee replacement. |
Ethics approval(s) | Berkshire Research Ethics Committee (REC), 20/11/2009, ref: 09/H0505/117 |
Health condition(s) or problem(s) studied | Trauma and Orthopaedics - total knee replacements |
Intervention | Patients who have total knee arthroplasty will be randomised into two groups. One group will have intramedullary plugging with retransfusion drains and one group will have retransfusion drains only. |
Intervention type | Procedure/Surgery |
Primary outcome measure | Allogenic blood transfusion requirements |
Secondary outcome measures | Post-operative blood loss assessed by: 1. Haemoglobin levels in first 3 days of the post-operative period 2. Total amount of blood collected in drain in the first 24 hours after surgery |
Overall study start date | 24/12/2009 |
Completion date | 30/01/2011 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Other |
Sex | Both |
Target number of participants | 100 |
Key inclusion criteria | 1. Male and female patients 2. Aged 50-90 years 3. Undergoing primary total knee replacement surgery |
Key exclusion criteria | Patients undergoing unicompartmental knee replacements and revision knee replacements |
Date of first enrolment | 24/12/2009 |
Date of final enrolment | 30/01/2011 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Royal Berkshire NHS Foundation Trust
Reading
RG1 5AN
United Kingdom
RG1 5AN
United Kingdom
Sponsor information
Royal Berkshire NHS Foundation Trust (UK)
Hospital/treatment centre
Hospital/treatment centre
c/o Leslie Frederick
Research and Development Office
Royal Berkshire NHS Foundation Trust
London Road
Reading
Reading
RG1 5AN
England
United Kingdom
https://ror.org/034nvrd87 |
Funders
Funder type
Hospital/treatment centre
Royal Berkshire NHS Foundation Trust (UK) - Trauma and Orthopaedic Department
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
22/05/2017: No publications found, verifying study status with principal investigator.